Epidermal growth factor receptor (EGFR) mutations mainly occur between exons 18 and 21 in non-small cell lung cancer (NSCLC), and are commonly found in never smokers, women, and patients with lung adenocarcinoma1,2. Here, EGFR is linked to non-small cell lung carcinoma.